)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Genmab
Genmab (GMAB) investor relations material
Genmab EGM 2026 presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.EGM 2026 presentation summary7 Oct, 2026
EGM agenda
Agenda covered the Board of Directors’ proposal and any other business.
Proposed 2026 board remuneration
Annual base cash fee: DKK 600,000 for a Board member; Chair fee 2.0x and Deputy Chair fee 1.5x the base fee.
RSU value: Chair 3.0x and Deputy Chair and Board members 2.5x the fixed annual base fee, under the Remuneration Policy.
Annual committee fees: Audit and Finance DKK 150,000 for Chair and DKK 100,000 for members; Compensation DKK 120,000 and DKK 80,000, respectively.
Annual committee fees: Nominating and Corporate Governance DKK 100,000 for Chair and DKK 70,000 for members; Scientific DKK 130,000 and DKK 100,000, respectively.
Committee meeting fee: DKK 10,000 per meeting.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Genmab
- DKK 2,166 million of 2019 profit was retained as key AGM resolutions passed.GMAB
AGM 2020 - FY2020 results approved; directors re-elected and governance, remuneration and capital proposals passed.GMABAGM 2021
- FY2021 accounts approved, DKK 3,008 million retained, and one new director elected.GMABAGM 2022
- AGM approved the 2022 accounts and adopted board, remuneration and treasury-share proposals.GMABAGM 2023
- 2023 accounts approved; directors re-elected and governance and capital proposals adopted.GMABAGM 2024
- Rina-S significantly improved PFS and OS in Phase 3 platinum-resistant ovarian cancer trial.GMABStudy result
- AbbVie collaboration pairs three bispecific programs with up to four discovery candidates.GMABCollaboration
- Pivotal phase III oncology readouts in Q4 2026 set up three major launches in 2027.GMABBank of America Global Healthcare Conference
- Rina-S® showed durable activity in gynecologic cancers, advancing toward Phase 3.GMABR&D Update
Next Genmab earnings date
Study result28 Oct, 2026
Genmab
Next Genmab earnings date
Study result28 Oct, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.